Tetra Bio-Pharma reports results from trial of ARDS-003 and Favipiravir

Onternabez plays a key role in mitigating the inflammatory response in various inflammatory condition targets.

Alzheimer’s disease drug development: three major questions for 2023

After a chaotic 2022 that saw both drug development successes and failures, the Alzheimer’s disease field faces questions over upcoming data and new therapeutic approaches.

Medidata unveils new app to accelerate start up of trial

The app is integrated with the Medidata Platform, including the Rave EDC, to offer a self-sustaining ecosystem.

US FDA grants clearance to commence trials of Sorrento’s mRNA vaccine

The microneedle system, along with an mRNA vaccine candidate, showed enhanced humoral immunity in animal models.